Microscopic Polyangiitis (MPA): Clinical Trials

1 trial for Microscopic Polyangiitis (MPA), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow Microscopic Polyangiitis (MPA): new trials by email Literature Review of Microscopic Polyangiitis (MPA) trials Research Report on Microscopic Polyangiitis (MPA)

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of IFX-1 to Replace Steroids in Patients With Granulomatosis With Polyangiitis and Microscopic Polyangiitis.
IFX-1, Placebo-IFX-1, Glucocorticoid (GC) - Granulomatosis With Polyangiitis (GPA), Microscopic Polyangiitis (MPA)
Phase 2CompletedInflaRx GmbH572019-04-032022-08-25

Narrower conditions

Granulomatosis with Polyangiitis (1)  ·  Microscopic Polyangiitis (1)  ·  Systemic Vasculitis (1)

Broader conditions

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (1)  ·  Autoimmune Diseases (1)  ·  Brain Diseases (1)  ·  Cardiovascular Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Cerebral Small Vessel Diseases (1)  ·  Cerebrovascular Disorders (1)  ·  Immune System Diseases (1)  ·  Lung Diseases (1)  ·  Lung Diseases, Interstitial (1)  ·  Nervous System Diseases (1)  ·  Respiratory Tract Diseases (1)  ·  Skin Diseases (1)  ·  Skin Diseases, Vascular (1)  ·  Skin and Connective Tissue Diseases (1)

Interventions

Glucocorticoids (1)  ·  Prednisone (1)  ·  vilobelimab (1)

Sponsors

InflaRx GmbH (1)

Countries

Belgium (1)  ·  Czechia (1)  ·  France (1)  ·  Germany (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Russia (1)  ·  Spain (1)  ·  Sweden (1)  ·  Switzerland (1)  ·  United Kingdom (1)

Top investigators

Anja Pfaff, PhD (1)  ·  Peter A. Merkel, MD, MPH (1)